D. P. Parkin - Concepedia

Author

D. P. Parkin

Also Known As

D P Parkin, D Parkin, D. P. PARKIN, D. P. Parkin, D. P. Parkin Parkin, D. Parkin, D.P. Parkin, DONALD P. PARKIN, DP Parkin, Donald P Parkin

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

Stellenbosch University Tygerberg Hospital St George's Hospital South African Medical Research Council

About

D. P. Parkin is an author at Stellenbosch University specializing in medicine, pharmacology, and tuberculosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	722
2	Health Sciences	2	2	179
3	Public Health	2	2	37
4	Allergy	1	1	191
5	Biochemistry	1	1	98

D. P. Parkin

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis. D. P. Parkin, Sam Vandenplas, F J Botha, American Journal of Respiratory and Critical Care Medicine Pulmonary TuberculosisAllergyTuberculosis PreventionPharmacologyEliminator Subgroups	1997	191
The Early Bactericidal Activity of Isoniazid Related to Its Dose Size in Pulmonary Tuberculosis PETER R. DONALD, FREDERICK A. SIRGEL, FREDERICK J. BOTHA, American Journal of Respiratory and Critical Care Medicine Tuberculosis PreventionBactericidal ActivityAntimicrobial ChemotherapyDrug ResistanceMedical Microbiology	1997	124
The influence of dose and N-acetyltransferase-2 (NAT2) genotype and phenotype on the pharmacokinetics and pharmacodynamics of isoniazid Peter R. Donald, D. P. Parkin, H. I. Seifart, European Journal of Clinical Pharmacology Pharmacological StudyMedicinePhysiologyPharmacotherapyPharmacology	2007	98
High-performance liquid chromatographic determination of isoniazid, acetylisoniazid and hydrazine in biological fluids H. I. Seifart, W. L. G. Gent, D. P. Parkin, Journal of Chromatography B Biomedical Sciences and Applications Biological FluidsChemical MeasurementBiochemistryGas ChromatographyMedicine	1995	98
The early bactericidal activity of rifabutin in patients with pulmonary tuberculosis measured by sputum viable counts: a new method of drug assessment Frederick A. Sirgel, Frederik J. H. Botha, D. P. Parkin, Journal of Antimicrobial Chemotherapy	1993	89
The Influence of Human N-Acetyltransferase Genotype on the Early Bactericidal Activity of Isoniazid Peter R. Donald, F A Sirgel, Amour Venter, Clinical Infectious Diseases	2004	89
The Early Bactericidal Activity of Ciprofloxacin in Patients with Pulmonary Tuberculosis FREDERICK A. SIRGEL, FREDERICK J. BOTHA, D. P. Parkin, American Journal of Respiratory and Critical Care Medicine	1997	62
Early bactericidal activity of ethambutol, pyrazinamide and the fixed combination of isoniazid, rifampicin and pyrazinamide (Rifater) in patients with pulmonary tuberculosis. F J Botha, F A Sirgel, D. P. Parkin, PubMed Antimicrobial ChemotherapyDrug ResistanceMedical MicrobiologyM. TuberculosisMycobacterium Tuberculosis	1996	55
Cerebrospinal Fluid Isoniazid Concentrations in Children With Tuberculous Meningitis: The Influence of Dosage and Acetylation Status PETER R. DONALD, W. L. G. Gent, H. I. Seifart, PEDIATRICS	1992	42
Early Bactericidal Activity of Paromomycin (Aminosidine) in Patients with Smear-Positive Pulmonary Tuberculosis Peter R. Donald, F A Sirgel, Thomas P. Kanyok, Antimicrobial Agents and Chemotherapy	2000	39

Page 1